Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. Our non-invasive EpiCheck platform delivers highly accurate and sensitive results, all while providing a seamless testing option for patients and the healthcare system. Our global team operates from San Diego, United States as well as from Rehovot Israel.
Find locations served, office locations
- Business Type:
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
This company also provides solutions for other industrial applications.
Please, visit the following links for more info: